These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19604259)

  • 1. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
    Levesque MC
    Clin Exp Immunol; 2009 Aug; 157(2):198-208. PubMed ID: 19604259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC; St Clair EW
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential utility of B cell-directed biologic therapy in autoimmune diseases.
    Arkfeld DG
    Rheumatol Int; 2008 Jan; 28(3):205-15. PubMed ID: 17957371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell-directed therapies for autoimmune disease.
    Dörner T; Radbruch A; Burmester GR
    Nat Rev Rheumatol; 2009 Aug; 5(8):433-41. PubMed ID: 19581902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in treatment-resistant autoimmune blistering skin disorders.
    Schmidt E; Bröcker EB; Goebeler M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):56-64. PubMed ID: 18270859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the B cell in vasculitis.
    Walsh M; Jayne D
    Pediatr Nephrol; 2009 Jul; 24(7):1267-75. PubMed ID: 18931860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell depletion in autoimmune disease.
    Gorman C; Leandro M; Isenberg D
    Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S17-21. PubMed ID: 15180893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
    Townsend MJ; Monroe JG; Chan AC
    Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell depletion and repopulation in autoimmune diseases.
    Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
    Perosa F; Prete M; Racanelli V; Dammacco F
    J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
    Mease PJ
    J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [B-cell-targeted therapy in the treatment of autoimmune diseases].
    Roll P; Tony HP
    Z Rheumatol; 2009 May; 68(3):255-9. PubMed ID: 19384549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
    Musette P; Bouaziz JD
    Front Immunol; 2018; 9():622. PubMed ID: 29706952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Ann Rheum Dis; 2007 May; 66(5):700-3. PubMed ID: 17040963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.
    Ly S; Nedosekin D; Wong HK
    Am J Clin Dermatol; 2023 Mar; 24(2):247-273. PubMed ID: 36630066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus].
    Terrier B; Mouthon L
    Med Sci (Paris); 2013 Jan; 29(1):65-73. PubMed ID: 23351696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.